Deadly Harvest: The Intimate Relationship Between Our Heath and Our Food (69 page)

382
White,
L.R., H. Petrovitch, G.W. Ross,
et al. “Brain Aging and Midlife Tofu Consumption.”
J Am Coll Nutr
19:2 (2000):
242–255
.

383
Seshadri, S., A.
Beiser, J. Selhub, et al.
“Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer’s Disease.”
N Engl J Med
346:7 (2002): 476–483. Clarke, R., A.D.
Smith, K.A. Jobst,
et al. “Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease.”
Arch Neurol
55:11 (1998):
1449–1455
.

Polidori, M.C., P.
Mattioli, S. Aldred S,
et al. “Plasma Antioxidant Status, Immunoglobulin G Oxidation and Lipid Peroxidation in Demented Patients: Relevance to Alzheimer Disease and Vascular Dementia.”
Dement Geriatr Cogn Disord
18:3–4 (2004):
265–270
.

384
Broadhurst, C.L., S.C. Cunnane, and M.A. Crawford. “Rift Valley Lake Fish and Shellfish Provided Brain-specific Nutrition for Early
Homo
.”
Br J Nutr
79:1 (1998): 3–21.

385
Panza, F., V.
Solfrizzi, A.M. Colacicco,
et al. “Mediterranean Diet and Cognitive Decline.”
Public Health Nutr
7:7 (2004):
959–963
.

Kalmijn, S., L.J.
Launer, A. Ott,
et al. “Dietary Fat Intake and the Risk of Incident Dementia in the Rotterdam Study.”
Ann Neurol
42:5 (1997):
776–782
. Barberger-Gateau, P., L.
Letenneur, V. Deschamps,
et al. “Fish, Meat, and Risk of Dementia: Cohort Study.”
Br Med J
325:7370 (2002):
932–933
.

Morris, M.C., D.A.
Evans, J.L. Bienias,
et al.
“Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease.”
Arch Neurol
60:7 (2003):
940–946
.

Kalmijn, S. “Dietary Fatty Acids and Cognitive Function.” In Mattson, Mark P. (ed.).
Diet-Brain Connections: Impact on Memory, Mood, Aging and Disease
.

Dordrecht: Kluwer Academic Publishers, 2002. Calon, F., G.P.
Lim, F. Yang, et al.
“Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer’s Disease Mouse Model.”
Neuron
43:5 (2004): 633–645.

386
Solfrizzi, V., F.
Panza, F. Torres,
et al.
“High Monounsaturated Fatty Acids Intake Protects against Age-Related Cognitive Decline.”
Neurology
52:8 (1999):
1563–1569
.

387
Mattson, M.P., W. Duan, and Z. Guo. “Meal Size and Frequency Affect Neuronal Plasticity and Vulnerability to Disease: Cellular and Molecular Mechanisms.”
J Neurochem
84:3 (2003): 417–431.

388
Mattson, M.P., S.L. Chan, and W. Duan. “Modification of Brain Aging and Neurodegenerative Disorders by Genes, Diet, and Behavior.”
Neurobiol Aging
23:5 (2002): 695–705.

389
Engelhart, M.J., M.I.
Geerlings, A. Ruitenberg,
et al. “Dietary Intake of Antioxidants and Risk of Alzheimer Disease.”
JAMA
287:24 (2002):
3223–3229
.

Morris, M.C., D.A.
Evans, J.L. Bienias,
et al.
“Dietary Intake of Antioxidant Nutrients and the Risk of Incident Alzheimer Disease in a Biracial Community Study.”
JAMA
287:24 (2002):
3230–3237
.

Corrada, M., C. Kawas, et al.
“Reduced Risk of Alzheimer’s Disease with High Folate Intake: The Baltimore Longitudinal Study of Aging.”
Alzheimer’s Dement
1:1 (2005): 11–18.

Wang,
H.X., A. Wahlin, H. Basun H, et al
.
“Vitamin B(12) and Folate in Relation to the Development of Alzheimer’s Disease.”
Neurology
56:9 (2001): 1188–1194. Marambaud, P., H.
Zhao, and P. Davies.
“Resveratrol Promotes Clearance of Alzheimer’s Disease Amyloid-beta Peptides.”
J Biol Chem
280:45 (2005): 37377–37382. Savaskan, E., G.
Olivieri, F. Meier, et al.
“Red Wine Ingredient Resveratrol Protects from Beta-amyloid Neurotoxicity.”
Gerontology
49:6 (2003): 380–383.

Heo, H.J., and C.Y.
Lee.
“Protective Effects of Quercetin and Vitamin C Against Oxidative Stress-induced Neurodegeneration.”
J Agric Food Chem
52:25 (2004): 7514–7517.

390
Polidori, M.C., P.
Mattioli, S. Aldred S,
et al. “Plasma Antioxidant Status, Immunoglobulin G Oxidation and Lipid Peroxidation in Demented Patients: Relevance to Alzheimer Disease and Vascular Dementia.”
Dement Geriatr Cogn Disord
18:3–4 (2004):
265–270
.

391
Clarke, R., A.D.
Smith, K.A. Jobst,
et al. “Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease.”
Arch Neurol
55:11 (1998):
1449–1455
.

392
Giem, P., W.L. Beeson, and G.E. Fraser. “The Incidence of Dementia and Intake of Animal Products: Preliminary Findings from the Adventist Health Study.”
Neuroepidemiology
12:1 (1993): 28–36.

393
Abbott, R., L.R.
White, G.W. Ross, et al.
“Walking and Dementia in Physically Capable Elderly Men.”
JAMA
292:12 (2004): 1447–1453.

394
Eriksson, P.S., E. Perfilieva, T. Bjork-Eriksson, et al.
“Neurogenesis in the Adult Human Hippocampus.”
Nature Med
4:11 (1998): 1313–1317.

395
Zelnik, N., A.
Pacht, R. Obeid, and A. Lerner.
“Range of Neurological Disorders in Patients with Celiac Disease.”
Pediatrics
113:6 (2004): 1672–1676.

396
Goldman, J., R.H.
Lerman, J.H. Contois, and J.N. Udall Jr.
“Behavioral Effects of Sucrose on Preschool Children.”
J Abnormal Child Psychol
14:4 (1986): 565–577.

Jones, T.W., W.P.
Borg, S.D. Boulware,
et al.
“Enhanced Adrenomedullary Response and Increased Susceptibility to Neuroglygopenia: Mechanisms Underlying the Adverse Effect of Sugar Ingestion in Children.”
J Pediatrics
126:2 (1995): 171–177.

397
Millstone, E. “Adverse Reactions to Food Additives: The Extent and Severity of the Problem.”
J Nutr Environ Med
7:4 (1997): 323–332.

Bateman, B., J.O.
Warner, E. Hutchinson,
et al. “The Effects of a Double-blind, Placebo-controlled, Artificial Food Colourings and Benzoate Preservative Challenge on Hyperactivity in a General Population Sample of Preschool Children.”
Arch Dis Child
89:6 (2004):
506–511
.

Eigenmann, P.A., and C.A. Haenggeli. “Food Colourings and Preservatives—Allergy and Hyperactivity.”
Lancet
364:9437 (2004):
823–824
.

398
Bateman, B., J.O.
Warner, E. Hutchinson, et al.
“The Effects of a Double-blind, Placebo-controlled, Artificial Food Colourings and Benzoate Preservative Challenge on Hyperactivity in a General Population Sample of Preschool Children.”
Arch Dis Child
89:6 (2004): 506–511.

399
Keeley, J. “Case Study: Appleton Central Alternative Charter High School’s Nutrition and Wellness Program.”
Better Food, Better Behavior
. Michael Fields Agricultural Institute, 2004. Available online at http://www.michaelfieldsaginst.org.

400
Mitchell, E.A., M.G.
Aman, S.H. Turbott, and M. Manku.
“Clinical Characteristics and Serum Essential Fatty Acid Levels in Hyperactive Children.”
Clin Pediatr (Philadelphia)
26:8 (1987):
406–411
.

Richardson, A.J., and B.K. Puri. “The Potential Role of Fatty Acids in Attention-Deficit/Hyperactivity Disorder.”
Prostaglandins Leukot Essent Fatty Acids
63:1–2 (2000): 79–87.

401
Stevens, L.J., S.S.
Zentall, M.L. Abate,
et al. “Omega-3 Fatty Acids in Boys with Behavior, Learning, and Health Problems.”
Physiol Behav
59:4–5 (1996):
915–920
.

402
Little, J. “Epidemiology of Neurodevelopmental Disorders in Children.”
Prostaglandins Leukot Essent Fatty Acids
63:1–2 (2000): 11–20.

Stevens, L.J., S.S.
Zentall, J.L. Deck,
et al. “Essential Fatty Acid Metabolism in Boys with Attention-Deficit Hyperactivity Disorder.”
Am J Clin Nutr
62:4 (1995): 761–768.

Colquhoun, I., and S. Bunday. “A Lack of Essential Fatty Acids as a Possible Cause of Hyperactivity in Children.”
Med Hypotheses
7:5 (1981):
673–679
.

Richardson, A.J., and B.K. Puri. “The Potential Role of Fatty Acids in Attention-Deficit/Hyperactivity Disorder.”
Prostaglandins Leukot Essent Fatty Acids
63:1–2 (2000): 79–87.

403
Bilici, M., F.
Yildirim, S. Kandil,
et al.
“Double-Blind, Placebo-Controlled Study of Zinc Sulfate in the Treatment of Attention Deficit Hyperactivity Disorder.”
Prog Neuropsychopharmacol Biol Psych
28:1 (2004):
181–190
.

Konofal, E., M.
Lecendreux, I. Arnulf, and M.C. Mouren.
“Iron Deficiency in Children with Attention-Deficit/Hyperactivity Disorder.”
Arch Pediatr Adolesc Med
158:12 (2004):
1113–1115
.

Kozielec, T., and B. Starobrat-Hermelin. “Assessment of Magnesium Levels in Children with Attention Deficit Hyperactivity Disorder (ADHD).”
Magnes Res
10:2 (1997):
143–148
.